Heparan sulfate deficiency leads to Peters anomaly in mice by disturbing neural crest TGF-β2 signaling

Journal of Clinical Investigation

Volumn 119, Issue 7, 2009, Pages 1997-2008

  Iwao, Keiichiro ^a,b   Inatani, Masaru ^a   Matsumoto, Yoshihiro ^c,d   Ogata Iwao, Minako ^a   Takihara, Yuji ^a   Irie, Fumitoshi ^d   Yamaguchi, Yu ^d   Okinami, Satoshi ^b   Tanihara, Hidenobu ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b SAGA UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; EXOSTOSIN-1; FORKHEAD TRANSCRIPTION FACTOR; FOXC1 PROTEIN, MOUSE; HEPARAN SULFATE; HOMEODOMAIN PROTEIN; INTEGRASE; N ACETYLGLUCOSAMINYLTRANSFERASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PITX2; TRANSFORMING GROWTH FACTOR BETA2; WNT1 PROTEIN; WNT1 PROTEIN, MOUSE;

ANIMAL; ANTERIOR EYE CHAMBER; C57BL MOUSE; CELL PROLIFERATION; CYTOLOGY; DEFICIENCY; GENETICS; GLAUCOMA; MOUSE; NEURAL CREST; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANTERIOR CHAMBER; CELL PROLIFERATION; FORKHEAD TRANSCRIPTION FACTORS; GLAUCOMA; HEPARITIN SULFATE; HOMEODOMAIN PROTEINS; INTEGRASES; MICE; MICE, INBRED C57BL; N-ACETYLGLUCOSAMINYLTRANSFERASES; NEURAL CREST; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA2; WNT1 PROTEIN;

EID: 68849125563     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/jci38519     Document Type: Article

References (65)

1. Maul, E., Strozzi, L., Munoz, C., and Reyes, C. 1980. The outflow pathway in congenital glaucoma. Am. J. Ophthalmol. 89:667-673.
2. Tawara, A., and Inomata, H. 1981. Developmental immaturity of the trabecular meshwork in congenital glaucoma. Am. J. Ophthalmol. 92:508-525.
3. Serbedzija, G.N., Bronner-Fraser, M., and Fraser, S.E. 1992. Vital dye analysis of cranial neural crest cell migration in the mouse embryo. Development. 116:297-307.
4. Langenberg, T., Kahana, A., Wszalek, J.A., and Halloran, M.C. 2008. The eye organizes neural crest cell migration. Dev. Dyn. 237:1645- 1652.
5. Cvekl, A., and Tamm, E.R. 2004. Anterior eye development and ocular mesenchyme: new insights from mouse models and human diseases. Bioessays. 26:374-386.
6. Gage, P.J., Rhoades, W., Prucka, S.K., and Hjalt, T. 2005. Fate maps of neural crest and mesoderm in the mammalian eye. Invest. Ophthalmol. Vis. Sci. 46:4200-4208.
7. Creuzet, S., Vincent, C., and Couly, G. 2005. Neural crest derivatives in ocular and periocular structures. Int. J. Dev. Biol. 49:161-171.
8. Adler, R., and Canto-Soler, M.V. 2007. Molecular mechanisms of optic vesicle development: complexities, ambiguities and controversies. Dev. Biol. 305:1-13.
9. Iwao, K., Inatani, M., Okinami, S., and Tanihara, H. 2008. Fate mapping of neural crest cells during eye development using a protein 0 promoter-driven transgenic technique. Graefes Arch. Clin. Exp. Ophthalmol. 246:1117-1122.
10. Ton, C.C., et al. 1991. Positional cloning and characterization of a paired box- and homeoboxcontaining gene from the aniridia region. Cell. 67:1059-1074.
11. Hanson, I.M., et al. 1994. Mutations at the PAX6 locus are found in heterogeneous anterior segment malformations including Peters' anomaly. Nat. Genet. 6:168-173.
12. Semina, E.V., et al. 1996. Cloning and characterization of a novel bicoid-related homeobox transcription factor gene, RIEG, involved in Rieger syndrome. Nat. Genet. 14:392-399.
13. Nishimura, D.Y., et al. 1998. The forkhead transcription factor gene FKHL7 is responsible for glaucoma phenotypes which map to 6p25. Nat. Genet. 19:140-147.
14. Hjalt, T.A., Amendt, B.A., and Murray, J.C. 2001. PITX2 regulates procollagen lysyl hydroxylase (PLOD) gene expression: implications for the pathology of Rieger syndrome. J. Cell Biol. 152:545-552.
15. Honkanen, R.A., et al. 2003. A family with Axenfeld-Rieger syndrome and Peters Anomaly caused by a point mutation (Phe112Ser) in the FOXC1 gene. Am. J. Ophthalmol. 135:368-375.
16. Tamimi, Y., et al. 2006. FGF19 is a target for FOXC1 regulation in ciliary body-derived cells. Hum. Mol. Genet. 15:3229-3240.
17. Strungaru, M.H., Dinu, I., and Walter, M.A. 2007. Genotype-phenotype correlations in Axenfeld-Rieger malformation and glaucoma patients with FOXC1 and PITX2 mutations. Invest. Ophthalmol. Vis. Sci. 48:228-237.
18. Weng, J., et al. 2008. Deletion of G protein-coupled receptor 48 leads to ocular anterior segment dysgenesis (ASD) through down-regulation of Pitx2. Proc. Natl. Acad. Sci. U S A. 105:6081-6086.
19. Traboulsi, E.I., and Maumenee, I.H. 1992. Peters' anomaly and associated congenital malformations. Arch. Ophthalmol. 110:1739-1742.
20. Saika, S., et al. 2001. TGFbeta2 in corneal morphogenesis during mouse embryonic development. Dev. Biol. 240:419-432.
21. Chang, B., et al. 2001. Haploinsufficient Bmp4 ocular phenotypes include anterior segment dysgenesis with elevated intraocular pressure. BMC Genet. 2:18.
22. Ittner, L.M., et al. 2005. Compound developmental eye disorders following inactivation of TGFbeta signaling in neural-crest stem cells. J. Biol. 4:11.
23. Newgreen, D., and Thiery, J.P. 1980. Fibronectin in early avian embryos: synthesis and distribution along the migration pathways of neural crest cells. Cell Tissue Res. 211:269-291.
24. Rovasio, R.A., Delouvee, A., Yamada, K.M., Timpl, R., and Thiery, J.P. 1983. Neural crest cell migration: requirements for exogenous fibronectin and high cell density. J. Cell Biol. 96:462-473.
25. Oakley, R.A., and Tosney, K.W. 1991. Peanut agglutinin and chondroitin-6-sulfate are molecular markers for tissues that act as barriers to axon advance in the avian embryo. Dev. Biol. 147:187-206.
26. Oakley, R.A., Lasky, C.J., Erickson, C.A., and Tosney, K.W. 1994. Glycoconjugates mark a transient barrier to neural crest migration in the chicken embryo. Development. 120:103-114.
27. Dutt, S., Kleber, M., Matasci, M., Sommer, L., and Zimmermann, D.R. 2006. Versican V0 and V1 guide migratory neural crest cells. J. Biol. Chem. 281:12123-12131.
28. Acott, T.S., and Kelley, M.J. 2008. Extracellular matrix in the trabecular meshwork. Exp. Eye Res. 86:543-561.
29. Tawara, A., and Inomata, H. 1994. Distribution and characterization of sulfated proteoglycans in the trabecular tissue of goniodysgenetic glaucoma. Am. J. Ophthalmol. 117:741-755.
30. Knepper, P.A., Goossens, W., Hvizd, M., and Palmberg, P.F. 1996. Glycosaminoglycans of the human trabecular meshwork in primary open-angle glaucoma. Invest. Ophthalmol. Vis. Sci. 37:1360-1367.
31. Kuleshova, O.N., Zaidman, A.M., and Korel, A.V. 2007. Glycosaminoglycans of the trabecular meshwork of the eye in primary juvenile glaucoma. Bull. Exp. Biol. Med. 143:381-384.
32. Rohen, J.W., Schachtschabel, D.O., and Berghoff, K. 1984. Histoautoradiographic and biochemical studies on human and monkey trabecular meshwork and ciliary body in short-term explant culture. Graefes Arch. Clin. Exp. Ophthalmol. 221:199-206.
33. Tawara, A., Varner, H.H., and Hollyfield, J.G. 1989. Distribution and characterization of sulfated proteoglycans in the human trabecular tissue. Invest. Ophthalmol. Vis. Sci. 30:2215-2231.
34. Jackson, S.M., et al. 1997. dally, a Drosophila glypican, controls cellular responses to the TGF-beta-related morphogen, Dpp. Development. 124:4113-4120.
35. Merz, D.C., Alves, G., Kawano, T., Zheng, H., and Culotti, J.G. 2003. UNC-52/perlecan affects gonadal leader cell migrations in C. elegans hermaphrodites through alterations in growth factor signaling. Dev. Biol. 256:173-186.
36. McCormick, C., et al. 1998. The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate. Nat. Genet. 19:158-161.
37. Lin, X., et al. 2000. Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice. Dev. Biol. 224:299-311.
38. Lind, T., Tufaro, F., McCormick, C., Lindahl, U., and Lidholt, K. 1998. The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate. J. Biol. Chem. 273:26265-26268.
39. Inatani, M., et al. 2003. Mammalian brain morphogenesis and midline axon guidance require heparan sulfate. Science. 302:1044-1046.
40. Sanford, L.P., et al. 1997. TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development. 124:2659-2670.
41. Pan, Y., Woodbury, A., Esko, J.D., Grobe, K., and Zhang, X. 2006. Heparan sulfate biosynthetic gene Ndst1 is required for FGF signaling in early lens development. Development. 133:4933-4944.
42. Nakanishi, I., and Brown, S.I. 1971. The histopathology and ultrastructure of congenital, central corneal opacity (Peters' anomaly). Am. J. Ophthalmol. 72:801-812.
43. Stone, D.L., Kenyon, K.R., Green, W.R., and Ryan, S.J. 1976. Congenital central corneal leukoma (Peters' anomaly). Am. J. Ophthalmol. 81:173-193.
44. Maillette de Buy Wenniger-Prick, L.J., and Hennekam, R.C. 2002. The Peters' plus syndrome: a review. Ann. Genet. 45:97-103.
45. Frydman, M., Weinstock, A.L., Cohen, H.A., Savir, H., and Varsano, I. 1991. Autosomal recessive Peters anomaly, typical facial appearance, failure to thrive, hydrocephalus, and other anomalies: further delineation of the Krause-Kivlin syndrome. Am. J. Med. Genet. 40:34-40.
46. Hennekam, R.C., et al. 1993. The Peters'-Plus syndrome: description of 16 patients and review of the literature. Clin. Dysmorphol. 2:283-300.
47. Waring, G.O., 3rd, Rodrigues, M.M., and Laibson, P.R. 1975. Anterior chamber cleavage syndrome. A stepladder classification. Surv. Ophthalmol. 20:3-27.
48. Lu, M.F., Pressman, C., Dyer, R., Johnson, R.L., and Martin, J.F. 1999. Function of Rieger syndrome gene in left-right asymmetry and craniofacial development. Nature. 401:276-278.
49. ten Dijke, P., Hansen, P., Iwata, K.K., Pieler, C., and Foulkes, J.G. 1988. Identification of another member of the transforming growth factor type beta gene family. Proc. Natl. Acad. Sci. U. S. A. 85:4715-4719.
50. Derynck, R., et al. 1988. A new type of transforming growth factor-beta, TGF-beta 3. EMBO J. 7:3737-3743.
51. Lyon, M., Rushton, G., and Gallagher, J.T. 1997. The interaction of the transforming growth factor-betas with heparin/heparan sulfate is isoform-specific. J. Biol. Chem. 272:18000-18006.
52. Belenkaya, T.Y., et al. 2004. Drosophila Dpp morphogen movement is independent of dynaminmediated endocytosis but regulated by the glypican members of heparan sulfate proteoglycans. Cell. 119:231-244.
53. Pellegrini, L., Burke, D.F., von Delft, F., Mulloy, B., and Blundell, T.L. 2000. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature. 407:1029-1034.
54. Trumpp, A., Depew, M.J., Rubenstein, J.L., Bishop, J.M., and Martin, G.R. 1999. Cre-mediated gene inactivation demonstrates that FGF8 is required for cell survival and patterning of the first branchial arch. Genes Dev. 13:3136-3148.
55. Kawauchi, S., et al. 2005. Fgf8 expression defines a morphogenetic center required for olfactory neurogenesis and nasal cavity development in the mouse. Development. 132:5211-5223.
56. Jeong, J., Mao, J., Tenzen, T., Kottmann, A.H., and McMahon, A.P. 2004. Hedgehog signaling in the neural crest cells regulates the patterning and growth of facial primordia. Genes Dev. 18:937-951.
57. Massague, J., and Chen, Y.G. 2000. Controlling TGF-beta signaling. Genes Dev. 14:627-644.
58. Lutjen-Drecoll, E. 2005. Morphological changes in glaucomatous eyes and the role of TGFbeta2 for the pathogenesis of the disease. Exp. Eye Res. 81:1-4.
59. Tripathi, R.C., Li, J., Chan, W.F., and Tripathi, B.J. 1994. Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. Exp. Eye Res. 59:723-727.
60. Inatani, M., et al. 2001. Transforming growth factor-beta 2 levels in aqueous humor of glaucomatous eyes. Graefes Arch. Clin. Exp. Ophthalmol. 239:109-113.
61. Picht, G., Welge-Luessen, U., Grehn, F., and Lutjen-Drecoll, E. 2001. Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefes Arch. Clin. Exp. Ophthalmol. 239:199-207.
62. Danielian, P.S., Muccino, D., Rowitch, D.H., Michael, S.K., and McMahon, A.P. 1998. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr. Biol. 8:1323-1326.
63. Soriano, P. 1999. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21:70-71.
64. Pankhurst, G.J., Bennett, C.A., and Easterbrook-Smith, S.B. 1998. Characterization of the heparin-binding properties of human clusterin. Biochemistry. 37:4823-4830.
65. Kanegae, Y., et al. 1995. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res. 23:3816-3821.